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Ablation for
Ventricular Tachycardia
Is More Always Better?
How Much More Is Too Much?*
Frank Bogun, MD, Thomas Crawford, MD
Ann Arbor, Michigan
Ventricular tachycardia (VT) remains one of the major
causes of morbidity and mortality after myocardial infarc-
tion (MI) (1,2). Surviving myofibers within scar tissue have
been shown to represent the arrhythmogenic substrate of
post-infarction VT (3). Identification of these myocytes and
myofiber bundles is possible by recording electrograms from
the scarred endocardium with a mapping catheter (4). This
can be best achieved while the patient is in VT. Unfortu-
nately, most VTs are not hemodynamically tolerated, and
therefore mapping during VT is not possible (5). Identifi-
cation of specific electrograms, mainly isolated potentials
during sinus rhythm, has been linked to critical sites of VT,
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thereby avoiding the search for critical areas during nontol-
erated VT (6). Although the majority of critical areas of
post-infarction VT are located in the endocardium, not all
components critical to a VT circuit can be reached from the
endocardium, and characterization of the entire circuit is
often not possible. It may be best to imagine the VT circuit
as a 3-dimensional structure that may have components in
the endocardium (most often the exit area), the mid-
myocardium, and the epicardium. How much of the circuit
is accessible endocardially is not known. Epicardial and
intramural re-entry circuit locations are well recognized in
the surgical literature and are an important cause of failure
of endocardial ablation (7,8).
Another problem of the mapping/ablation procedure for
VT is the difficulty and often unreliability of VT inducibil-
ity. Procedural endpoints may therefore be unreliable as
well. Noninducibility is the preferred outcome of an abla-
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this endpoint with improved long-term outcome (9). Lack
of inducibility of VT after ablation, however, does not
unequivocally predict a better outcome after ablation (10).
Therefore, other endpoints and ablation techniques must be
sought. Scar homogenization might be a such a technique
that addresses the entire scar and may improve long-term
outcome, provided that patients are noninducible after the
ablation procedure. This innovative ablation approach for
patients presenting with electrical storm (ES) is presented
by Di Biase et al. (11) in this issue of the Journal.
Ninety-two consecutive patients with ischemic cardiomy-
opathy and ES were enrolled at 5 centers. Forty-nine
patients underwent conventional endocardial mapping and
ablation of select areas based on activation, entrainment,
substrate mapping, and pace mapping (Group 1). The
subsequent 43 patients (Group 2) underwent both percuta-
neous endocardial and epicardial mapping and ablation of
all abnormal potentials within and around the scar (homog-
enization procedure). Four patients in Group 1 also under-
went epicardial mapping and ablation, as VT was still
inducible after endocardial ablation. In both groups the
electrophysiological endpoint was VT noninducibility. Al-
though in Group 2 all patients underwent epicardial map-
ping, only 14 (33%) had ablation performed in the pericar-
dial space due to the presence of delayed, fragmented, or low
voltage potentials. The authors report a 100% VT nonin-
ducibility rate with 3 extrastimuli and isoproterenol (up to
5 g/min) at the end of the ablation in both groups.
Ablation with endo- and epicardial homogenization was
associated with dramatically lower VT recurrence rate (haz-
ard ratio: 0.38, p  0.019). However, before adopting this
technique, several issues need to be addressed:
● This is not a randomized study. The first group was more
of a historical comparison, with a longer follow-up than the
second group, although the analysis performed with a
shorter follow-up time tried to adjust for this fact.
However, more long-term follow-up is necessary in order
to fully assess the value of different ablation techniques.
● The endpoints of the scar homogenization technique are
not fully described, and it is not clear how much ablation
is required at each site where radiofrequency energy is
delivered. If the endpoint was to render the entire scar
nonexcitable, then this would have been a clear endpoint;
however, this is difficult and potentially impossible to
achieve with current ablation catheters. Several areas
probably would need more ablation than other areas to
render a particular VT noninducible, but no data are
provided regarding this issue. For example, if VTs remain
inducible in the “homogenization group” after the entire
scar is covered with ablation lesions, identifying the areas
that require more ablation requires a more localizing
approach, such as pace mapping. This argues for a
procedure that would take both electrogram characteris-
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advantages if the clinical VTs are not inducible.
A large part of the population currently undergoing VT
ablation in the United States has had prior coronary
artery bypass grafting and therefore would not be eligible
for a percutaneous epicardial ablation procedure (12).
The true value of the epicardial approach is not clear from
the study design, although it appears that patients who
underwent an epicardial approach did not have a better
outcome compared with patients who underwent an endocar-
dial approach only.
The investigators ought to be congratulated in achieving
100% noninducibility in all patients with both ap-
proaches. The participating centers are very experienced
in complex ablation procedures, and one needs to be
careful in extrapolating the results to other centers.
Although the technique of ablating the entire scar may
seem appealing, it remains to be seen whether the
excellent results of midterm follow-up can be replicated
with essentially no periprocedural complications despite
an epicardial approach in half of the patients. This is
surprising in view of the complications described even in
experienced centers with an epicardial approach (13,14).
Furthermore, no additional anticoagulation was used
after ablation despite a more encompassing ablation
approach. Current expert opinions do call for at least
temporary anticoagulation if more extensive ablation is
performed (15).
In summary, the study by Di Biase et al. (11) presents a
ovel approach to ablation of ES after myocardial infarc-
ion. This approach provides some evidence in favor of
issue homogenization as an ablation strategy. Further
tudies are needed, however, to determine the incremental
enefit—if any—of the epicardial ablation portion used in
his method, in light of the potential complications that
uch an approach carries.
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